These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34089326)

  • 21. Atypical meningoma: current management dilemmas and prospective clinical trials.
    Jenkinson MD; Weber DC; Haylock BJ; Mallucci CL; Zakaria R; Javadpour M
    J Neurooncol; 2015 Jan; 121(1):1-7. PubMed ID: 25258253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant radiotherapy for atypical meningiomas.
    Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
    J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant Radiotherapy Did Not Reduce Recurrence of World Health Organization Grade I Meningiomas with Venous Sinus Involvement: A Propensity Score Adjusted Analysis and Literature Review.
    Gomes Dos Santos A; Solla DJF; Moscardi R; Neville IS; Weltman E; Teixeira MJ; Paiva WS
    World Neurosurg; 2019 Oct; 130():e1015-e1019. PubMed ID: 31306847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of radiotherapy following gross-total resection of atypical meningiomas.
    Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
    J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
    Wu A; Jin MC; Meola A; Wong HN; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical and anaplastic meningiomas--does the new WHO-classification of brain tumours affect the indication for postoperative irradiation?
    Hoffmann W; Mühleisen H; Hess CF; Kortmann RD; Schmidt B; Grote EH; Bamberg M
    Acta Neurochir (Wien); 1995; 135(3-4):171-8. PubMed ID: 8748810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: radiosurgery and atypical meningiomas.
    Elder JB; Chiocca EA
    J Neurosurg; 2012 Oct; 117(4):676-8. PubMed ID: 22920959
    [No Abstract]   [Full Text] [Related]  

  • 30. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
    Sá-Marta E; Alves JL; Rebelo O; Barbosa M
    World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
    Dziuk TW; Woo S; Butler EB; Thornby J; Grossman R; Dennis WS; Lu H; Carpenter LS; Chiu JK
    J Neurooncol; 1998 Apr; 37(2):177-88. PubMed ID: 9524097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. World Health Organization grade II meningiomas.
    Champeaux C; Dunn L
    Acta Neurochir (Wien); 2016 May; 158(5):921-9; discussion 929. PubMed ID: 27020441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
    Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
    Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
    Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter to the Editor Regarding "World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment".
    Wang Y; Gao X; Ge Y
    World Neurosurg; 2018 Apr; 112():304. PubMed ID: 29580021
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Reply to the Letter to the Editor Regarding "World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment".
    Liu X; Shan B; Wang M; Xu J
    World Neurosurg; 2018 Apr; 112():305. PubMed ID: 29288859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.